Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,892.00
-24.00 (-1.25%)
At close: Jul 7, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 147.11 billion as of July 7, 2026. Its market cap has decreased by -49.66% in one year.
Market Cap
147.11B
Enterprise Value
231.54B
Revenue
18.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,892.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 147.11B, a decrease of -76.01%. That is a compound annual growth rate of -23.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 147.11B | -37.66% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 193.14B |
| Kanaph Therapeutics | 192.34B |
| Y-Biologics | 178.19B |
| Ensol Biosciences | 172.98B |
| Genome & Company | 169.87B |
| Bio Solution | 152.50B |
| ISU Abxis | 141.90B |
| TiumBio | 124.81B |